Global health sector strategies on, respectively, HIV, viral hepatitis, and sexually transmitted infections for the period 2022-2030 guide the health sector in implementing strategically focused responses
This report provides accountability for the 3 Global Health Sector Strategies (2016-2021) on HIV, Viral Hepatitis and the STIs. The report assesses the impact, progress and gaps, and identifies actions
<p>The device called “AJO-Neo” is developed by Professor Samir K. Pal &his group at S.N. Bose National Centre For Basic Sciences (SNBNCBS), Kolkata, an autonomous research Institute under
<p>The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries.<a href="http://www.indiaenvironmentportal.org.in/files/file/hepatitis-C-South-Korea.pdf"
Account for 22 per cent of total deaths in two years Tuberculosis, HIV and Hepatitis-C are the biggest killer in jails in the state. The fact came to the fore in a recent study. As per a study on
Cases of hepatitis-C are increasing in the district every year. Health Department data says the district has witnessed 6.5-fold increase in cases between 2014 and 2018. Hepatitis-C can lead to severe complications,
The National Viral Hepatitis Control Programme, a new initiative under the National Health Mission, marks the beginning of the nation’s journey to control Viral Hepatitis and thereby reducing mortality
In line with the Government of India’s deep commitment towards elimination of viral hepatitis, the “National Action Plan – Viral Hepatitis” was launched by Union Minister of State, Health & Family Welfare.
<p>The revolution in hepatitis C virus (HCV) treatment through the development of direct-acting antivirals (DAAs) has generated international interest in the global elimination of the disease as a public
Currently, immunisation against hepatitis B requires injectable vaccines, with the first booster shot after one month, and the second after six months. Two years after researchers at the All India Institute
